These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Counseling teens and young women on Depo-Provera. Tonelli M; Nicoletti A J Pediatr Adolesc Gynecol; 2005 Aug; 18(4):297-8. PubMed ID: 16171737 [No Abstract] [Full Text] [Related]
25. Injectable contraceptives: a worldwide perspective. Affandi B J Fam Plann Reprod Health Care; 2002 Jan; 28(1):3-4. PubMed ID: 16259804 [No Abstract] [Full Text] [Related]
31. Depot medroxyprogesterone acetate in teens: A risk for bone health? Bachrach LK; Cundy T; Ott SM Pediatrics; 2000 Nov; 106(5):1137-8. PubMed ID: 11061788 [No Abstract] [Full Text] [Related]
32. Monthly injection provides new contraceptive choice. FDA Consum; 2001; 35(1):5. PubMed ID: 11930928 [No Abstract] [Full Text] [Related]
33. Thrombocytopenic purpura with depot medroxyprogesterone acetate and subsequent use of contraceptive implant: making decisions in the absence of evidence. Holman R; Stephen G J Fam Plann Reprod Health Care; 2005 Oct; 31(4):333-4. PubMed ID: 16274569 [No Abstract] [Full Text] [Related]
34. Clinical experience with injectable progestogen- only contraceptives at University of Ilorin teaching hospital: a five year review. Balogun OR; Raji HO Niger Postgrad Med J; 2009 Dec; 16(4):260-3. PubMed ID: 20037621 [TBL] [Abstract][Full Text] [Related]
39. Serum medroxyprogesterone acetate levels in new and repeat users of depot medroxyprogesterone acetate at the end of the dosing interval. Smit J; Botha J; McFadyen L; Beksinska M Contraception; 2004 Jan; 69(1):3-7. PubMed ID: 14720612 [TBL] [Abstract][Full Text] [Related]
40. Urinary tract infection in the users of depot-medroxyprogesterone acetate. Berger RE J Urol; 2005 Sep; 174(3):941. PubMed ID: 16093999 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]